Larson Financial Group’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
ACA
FLPIM
Larson Financial Group's CRDF Position: Q3 2025 in Review
Larson Financial Group sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 328 shares — an estimated $1.03K sold.
Larson Financial Group first reported a position in CRDF in Q4 2021 and held it in 7 quarters. The position peaked at $1.03K in Q2 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.
- Larson Financial Group reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
- Larson Financial Group sold 328 Cardiff Oncology shares in Q3 2025, an estimated $1.03K.
- Larson Financial Group first reported a position in Cardiff Oncology in Q4 2021 and held it in 7 quarters.
- Larson Financial Group's Cardiff Oncology position peaked at $1.03K in Q2 2025.
- 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.
Based on Larson Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.